Biogen Idec has created a new research consortium with several leading academic research centers that will leverage a range of scientific techniques and disciplines to identify new approaches to treating amyotrophic lateral sclerosis (ALS). The consortium will coordinate research and share results across a number of different disciplines with the goal of accelerating the understanding of the disease and the development of new targets.   Each participating lab will undertake a three-year research...